Medical Journals

Signaling and Regulation of Endothelial Cell Survival by Angiopoietin-2.

Authors:
  • Harfouche Rania
  • Hussain Sabah N A

From: Rm. L3.05, Critical Care Division, Royal Victoria Hospital, 687 Pine Ave West, Montreal, Quebec, Canada.

American journal of physiology. Heart and circulatory physiology

  • Publish Date: Oct 2006
  • ISSN: 0363-6135
  • Volume: 291
  • Issue: 4
  • Pages: H1635-45
  • Medium: Print
  • Language: English
  • Citation (JAMA): Harfouche Rania, Hussain Sabah N A, et al. Signaling and Regulation of Endothelial Cell Survival by Angiopoietin-2.. Am. J. Physiol. Heart Circ. Physiol. Oct 2006;291:H1635-45

Abstract

Angiopoietins are ligands for endothelial cell-specific Tie-2 receptors. Whereas angiopoietin-1 (Ang-1) activates these receptors and promotes cell survival, migration, and sprouting, little information is available regarding how Ang-2 influences these cells. In this study, we evaluated signaling pathways and biological effects of physiological concentrations of Ang-2 in cultured human umbilical vein endothelial cells. Ang-2 at 150 and 300 ng/ml elicited a transient (reaching peak values within 15 min of exposure) increase in the phosphorylation of Tie-2 receptors, protein kinase B (Akt), ERK1/2, and p38 members of the mitogen-activated protein kinases. However, unlike Ang-1, Ang-2 significantly inhibited JNK/SAPK phosphorylation. When vascular endothelial growth factor (VEGF) was present along with Ang-2, ERK1/2 phosphorylation was inhibited, whereas augmentation of Ang-1-induced ERK1/2 phosphorylation was triggered by VEGF. Ang-2 treatment had no effect on cell migration and in vitro wound healing but significantly attenuated serum deprivation-induced apoptosis and promoted survival. These effects were completely reversed by phosphatidylinositol 3 (PI3)-kinase and ERK1/2 inhibitors but were augmented by an inhibitor of the p38 pathway. These results suggest that Ang-2 promotes endothelial cell survival through the ERK1/2 and PI3-kinase pathways and that this angiopoietin is not a strong promoter of endothelial cell migration. We also conclude that the nature of interactions in terms of ERK1/2 activation between Ang-2 and VEGF is different from that of Ang-1 and VEGF.

Mesh Headings (Keywords): 1-Phosphatidylinositol 3-Kinase, Angiopoietin-2, Apoptosis, Cell Movement, Cell Survival, Cells, Cultured, Endothelial Cells, Endothelium, Vascular, Humans, Mitogen-Activated Protein Kinase 3, Mitogen-Activated Protein Kinases, Phosphorylation, Proto-Oncogene Proteins c-akt, Receptors, TIE, Signal Transduction, Vascular Endothelial Growth Factor A


Check for Full Text / PubMed Unique Identifier (PMID): 16714355


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.